PROGENy enrichment analysis further validated the molecular pathway differences between subgroups (Figure 3B), which showed that C2 and C3 were significantly enhanced in pathways related to tumor development and metastasis, including EGFR, Hypoxia, MAPK, PI3K, VEGF, and WNT pathways. The gene discussed is EGFR; the disease is neoplasm.